GlassScriptPhysician profile
John Kerwin Trussell
NPI 1114287398
$3,322.27
in general payments reported to CMS, 2019-2025
23 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $249 · 2021: $314 · 2022: $194 · 2023: $1,343 · 2024: $441 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Travel and Lodging: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.40 |
| Travel and Lodging | $729.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $973.68 | 2020-2023 | Da Vinci Surgical System |
| Olympus America INC. | $387.76 | 2019-2023 | 4k Cable 8.5m |
| Abbvie INC. | $378.55 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $312.77 | 2019-2024 | Acessa Provu System, Aptima |
| Aspira Women'S Health INC | $185.21 | 2020-2024 | Ova1 |
| Exeltis, USA INC. | $167.79 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $137.32 | 2019-2025 | |
| Astellas Pharma US INC | $129.49 | 2023-2025 | Veozah, Myrbetriq |
| Organon LLC | $122.25 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $93.99 | 2019-2024 | Endosee, Summit Doppler, Paragard T 380a |
| Biogen, INC. | $82.92 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $58.33 | 2025 | Myfembree, Gemtesa |
| Duchesnay USA Incorporated | $49.68 | 2019 | |
| Daiichi Sankyo INC. | $42.31 | 2019-2022 | |
| Pfizer INC. | $42.18 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $33.47 | 2024-2025 | |
| Avion Pharmaceuticals | $24.73 | 2020-2021 | |
| Roche Diagnostics Corporation | $20.86 | 2019 | |
| Baxter Healthcare | $19.54 | 2025 | Perclot |
| Allergan, INC. | $19.02 | 2019 | |
| Kci USA, INC. | $14.42 | 2021 | |
| Boston Scientific Corporation | $13.97 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Minerva Surgical, INC | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Trussell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.